Apoptosis and the Pathogenesis of Endometriosis

Apoptosis is a physiologic process that deletes unwanted cells without inducing an inflammatory reaction. Survival of endometriotic implants is associated with decreased apoptosis and an inflammatory environment. The most widely accepted theory-transplantation theory-related to the pathogenesis of endometriosis is supported by the description of abnormal survival of regurgitated endometrial cells. Eutopic endometrial cells from women with endometriosis also seem to resist apoptosis further when compared with cells from disease-free women. Several apoptotic pathways have been studied. Recent literature concerning apoptosis-related genes such as bcl-2/bax and fas/fas ligand is summarized in this article. Special emphasis is placed on sex steroid modulation and cell adhesion regulation, both relevant in early events of endometriosis.

Apoptosis - bcl-2 - fas ligand - endometrium

- 1 Ashkenazi A, Dixit V M. Death receptors: signaling and modulation. Science . 1998; 281 1305-1308 - 2 Clarke P G, Clarke S. Historic apoptosis. Nature . 1995; 378 230 - 3 Lincz L. Deciphering the apoptotic pathway: all roads lead to death. Immunol Cell Biol . 1998; 76 1-19 - 4 Kerr J F, Wyllie A H, Currie A R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer . 1972; 26 239-257 - 5 Cohen G M, Sun X-M, Snowden R T, Dinsdale D, Skilleter D N. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J . 1992; 286 331-334 - 6 Tsujimoto Y, Cossman J, Jaffe E, Croce C. Involvement of the bcl-2 gene in human follicular lymphoma. Science . 1985; 228 1440-1443 - 7 Vaux D, Cory S, Adams J. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature . 1988; 335 440-442 - 8 Hunter J J, Parslow T G. A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis. J Biol Chem . 1996; 271 8521-8524 - 9 Tilly J L. Apoptosis and ovarian function. Rev Reprod . 1996; 1 162-172 - 10 Nagata S, Golstein P. The Fas death factor. Science . 1995; 267 1449-1456 - 11 Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell . 1993; 75 1169-1178 - 12 Watanabe-Fukunaga R, Brannan C, Itoh N. et al . The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol . 1992; 148 1274-1279 - 13 Suda T, Okazaki T, Naito Y. et al . Expression of the Fas ligand in T-cell-lineage. J Immunol . 1995; 154 3806-3813 - 14 Nagata S. Fas and Fas ligand: a death factor and its receptor. Adv Immunol . 1994; 57 129-135 - 15 Dao T, Ohashi K, Kayano T, Kurimoto M, Okamura H. Interferon-γ-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol . 1996; 173 230-235 - 16 Strand S, Hofmann W, Hug H. et al . Lymphocyte apoptosis induced by CD94 (APO-1 Fas) ligand-expressing tumor cells: a mechanism of immune evasion?. Nat Med . 1996; 2 1361-1366 - 17 Nagata S. Apoptosis by death factor. Cell . 1997; 88 355-365 - 18 Griffith T, Brunner T, Fletcher S, Gree D, Ferguson T. Fas ligand induces apoptosis as a mechanism of immune privilege. Science . 1995; 270 1187-1192 - 19 Bellgrau D, Gold D, Selawry H. et al . A role for CD95 ligand in preventing graft rejection. Science . 1995; 377 630-632 - 20 Runic R, Lockwood C, Ma Y, Dipasquale B, Guller S. Expression of Fas ligand by human cytotrophoblast: implications in placentation and fetal survival. J Clin Endocrinol Metab . 1997; 81 3119-3122 - 21 Mor G, Gutierrez L, Eliza M, Kahyaoglu F, Arici A. Fas-Fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease. Am J Reprod Immunol . 1998; 39 89-94 - 22 Rabinowich H, Reichert T E, Kashii Y. et al . Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes. J Clin Invest . 1998; 101 2579-2588 - 23 Tabibzadeh S, Zupi E, Babaknia A. et al . Site and menstrual cycle-dependant expression of proteins of the tumour necrosis factor (TNF) receptor family, and BCL-2 oncoprotein and phase-specific production of TNFα in human reproduction. Hum Reprod . 1995; 10 277-286 - 24 Dahmoun M, Boman K, Cajander S. et al . Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of secretory phase. J Clin Endocrinol Metab . 1999; 84 1737-1743 - 25 Kokawa K, Shikone T, Nakano R. Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrinol Metab . 1996; 81 4144-4147 - 26 Garcia-Velasco J A, Arici A, Zreik T, Naftolin F, Mor G. Macrophage-derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: a role in endometriosis. Mol Hum Reprod . 1999; 5 642-650 - 27 Gebel H M, Braun D P, Tambur A. et al . Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis. Fertil Steril . 1998; 69 1042-1047 - 28 Dmowski W P. Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis. Hum Reprod . 2001; 16 1802-1808 - 29 Meresman G F, Vighi S, Buquet R A. et al . Apoptosis and expression of bcl-2 and bax in eutopic endometrium of women with endometriosis. Fertil Steril . 2000; 74 760-766 - 30 Suganuma N, Harada M, Furuhashi M, Nawa A, Kikkawa F. Apoptosis in human endometrial and endometriotic tissues. Horm Res . 1997; 48 (suppl 1) 42-47 - 31 Harada M, Suganuma N, Furuhashi M. et al . Detection of apoptosis in human endometriotic tissues. Mol Hum Reprod . 1996; 2 307-315 - 32 Meredith J, Fazeli B, Schwartz M. The extracellular matrix as a survival factor. Mol Biol Cell . 1993; 4 953-961 - 33 Aplin A E, Howe A, Alahari S K, Juliano R L. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev . 1998; 50 197-263 - 34 Franke T F, Cantley L C. A bad kinase makes good. Nature . 1997; 390 116-117 - 35 Wary K K, Mainiero F, Isakoff S J, Marcantonio E E, Giancotti F G. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell . 1996; 87 733-743 - 36 Shy J-J, Chien S. Role of integrins in cellular responses to mechanical stress and adhesion. Curr Opin Cell Biol . 1997; 9 707-713 - 37 Koh E, Illingworth P, Duncan W, Critchley H. Immunolocalization of bcl-2 protein in human endometrium in the menstrual cycle and simulated early pregnancy. Mol Hum Reprod . 1995; 10 1557-1562 - 38 Otsuki Y, Misaki O, Sugimoto O. et al . Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle. Lancet . 1994; 344 28-29 - 39 Jones R, Searle R, Stewart J, Turner S, Bulmer J. Apoptosis, bcl-2 expression, and proliferative activity in human endometrial stroma and endometrial granulated lymphocytes. Biol Reprod . 1998; 58 995-1002 - 40 Yamashita H, Otsuki Y, Ito Y. et al . Fas ligand, Fas antigen and Bcl-2 expression in human endometrium during the menstrual cycle. Mol Hum Reprod . 1999; 5 358-364 - 41 Meresman G, Augé L, Barañao R I. et al . Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril . 2002; 77 1141-1147 - 42 McLaren J, Prentice A, Charnock-Jones D, Sharkey A, Smith S. Immunolocalization of the apoptosis regulating proteins Bcl-2 and Bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis. Hum Reprod . 1997; 12 146-152 - 43 Juliano R L, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol . 1993; 120 577-585 - 44 Spuijbroek M E H D, Dunselman G AJ, Menheere P C A P, Evers J LH. Early endometriosis invades the extracellular matrix. Fertil Steril . 1992; 58 929-933 - 45 Witz C A, Motoya-Rodríguez I A, Schenken R S. Whole explants of peritoneum and endometrium: a novel model of the early endometriosis lesion. Fertil Steril . 1999; 71 56-60 - 46 Garcia-Velasco J A, Arici A. Chemokines in human reproduction. Infertil Reprod Med Clin North Am . 2002; 13 129-144 - 47 Simón C, Caballero P, Garcia-Velasco J A, Pellicer A. Potential implications of chemokines in reproductive function: an attractive idea. J Reprod Immunol . 1998; 38 169-193 - 48 Garcia-Velasco J A, Seli E, Arici A. Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by integrin-dependent cell adhesion. Biol Reprod . 1999; 61 548-552 - 49 Garcia-Velasco J A, Arici A. Interleukin-8 expression in endometrial stromal cells is regulated by integrin-dependent cell adhesion. Mol Hum Reprod . 1999; 12 1135-1140 - 50 Selam B, Kayisli U A, Garcia-Velasco J A, Arici A. Extracellular matrix-dependent regulation of Fas ligand expression in human endometrial stromal cells. Biol Reprod . 2002; 66 1-5 - 51 Arici A, Tazuke S I, Attar E, Kliman H J, Olive D L. Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Mol Hum Reprod . 1996; 2 40-45 - 52 Ryan I P, Tseng J F, Schriock E D. et al . Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril . 1995; 63 929-932 - 53 Selam B, Kayisli U A, Garcia-Velasco J A, Akbas E, Arici A. Regulation of Fas ligand expression by interleukin-8 in human endometrium. J Clin Endocrinol Metab . 2002; 87 3921-3927 - 54 Kayagaki N, Kawasaki A, Ebata T. et al . Metalloproteinase-mediated release of human Fas ligand. J Exp Med . 1995; 182 1777-1783 - 55 Tanaka M, Suda T, Haze K. et al . Fas ligand in human serum. Nat Med . 1996; 2 317-322 - 56 Osteen K G, Bruner-Tan K L, Ong D, Eisenberg E. Paracrine mediators of endometrial matrix metalloproteinases expression: potential targets for progestin-based treatment of endometriosis. Ann NY Acad Sci . 2002; 955 139-146 - 57 Garcia-Velasco J A, Mulayim N, Kayisli U A, Arici A. Elevated soluble Fas ligand levels may suggest a role for apoptosis in women with endometriosis. Fertil Steril . 2002; 78 855-859